These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 34124187)

  • 1. COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus.
    Al-Kuraishy HM; Al-Gareeb AI; Alblihed M; Guerreiro SG; Cruz-Martins N; Batiha GE
    Front Cardiovasc Med; 2021; 8():644095. PubMed ID: 34124187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus.
    Liao YH; Zheng JQ; Zheng CM; Lu KC; Chao YC
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33297431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.
    Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.
    Subbaram K; Ali PSS; Ali S
    Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between hyperglycemia and the infection of COVID-19 in diabetic patients: A protocol for systematic review and meta-analysis.
    Liu Y; Yang Y; Chen Y; Zhou L; Xiong Q; Xie C
    Medicine (Baltimore); 2020 Sep; 99(36):e21806. PubMed ID: 32899010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection.
    Vargas-Rodriguez JR; Garza-Veloz I; Flores-Morales V; Badillo-Almaraz JI; Rocha-Pizaña MR; Valdés-Aguayo JJ; Martinez-Fierro ML
    Front Med (Lausanne); 2021; 8():758414. PubMed ID: 35096863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic Ketoacidosis and COVID-19: A Retrospective Observational Study.
    Nagdev G; Chavan G; Gadkari C; Sahu G
    Cureus; 2022 Oct; 14(10):e30895. PubMed ID: 36465737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management.
    Memon SS; Biswas DA
    Cureus; 2022 Nov; 14(11):e31895. PubMed ID: 36579192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
    Zangiabadian M; Nejadghaderi SA; Zahmatkesh MM; Hajikhani B; Mirsaeidi M; Nasiri MJ
    Front Endocrinol (Lausanne); 2021; 12():645194. PubMed ID: 33815295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemic Emergencies Associated With COVID-19 Vaccination: A Case Series and Discussion.
    Lee HJ; Sajan A; Tomer Y
    J Endocr Soc; 2021 Nov; 5(11):bvab141. PubMed ID: 34604689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the gene expression of SARS-COV-2 entry receptors and enzymes in lungs and hearts of controlled and uncontrolled diabetic mice.
    Alkhawaldeh O; Jarrar Y; Gharaibeh M; Abudahab S; Abulebdah D; Jarrar B
    Fundam Clin Pharmacol; 2024 Apr; 38(2):328-340. PubMed ID: 37950353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection.
    Rasmi Y; di Bari I; Faisal S; Haque M; Aramwit P; da Silva A; Roshani Asl E
    Mol Biol Rep; 2024 Feb; 51(1):316. PubMed ID: 38376656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and Diabetes: will Novel Drugs for Diabetes Help in COVID-19?
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Dubey R; Prabhakar PK; Batiha GE
    Curr Mol Pharmacol; 2023; 16(4):494-506. PubMed ID: 36089790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
    Bassendine MF; Bridge SH; McCaughan GW; Gorrell MD
    J Diabetes; 2020 Sep; 12(9):649-658. PubMed ID: 32394639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes.
    Shao S; Yang Q; Pan R; Yu X; Chen Y
    Front Endocrinol (Lausanne); 2021; 12():731974. PubMed ID: 34690930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the Interrelationship between COVID-19 and Diabetes Mellitus.
    Roham PH; Kamath JJ; Sharma S
    Adv Biol (Weinh); 2023 Aug; 7(8):e2300107. PubMed ID: 37246237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review.
    Magdy Beshbishy A; Oti VB; Hussein DE; Rehan IF; Adeyemi OS; Rivero-Perez N; Zaragoza-Bastida A; Shah MA; Abouelezz K; Hetta HF; Cruz-Martins N; Batiha GE
    Front Public Health; 2021; 9():591982. PubMed ID: 34307267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycemia induced cathepsin L maturation linked to diabetic comorbidities and COVID-19 mortality.
    He Q; Zhao MM; Li MJ; Li XY; Jin JM; Feng YM; Zhang L; Huang WJ; Yang F; Yang JK
    Elife; 2024 Aug; 13():. PubMed ID: 39150053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors.
    Vitale RJ; Valtis YK; McDonnell ME; Palermo NE; Fisher NDL
    AACE Clin Case Rep; 2021; 7(1):10-13. PubMed ID: 33521255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.